Compounds as pharmaceutical agents

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S139000, C546S275700

Reexamination Certificate

active

10535381

ABSTRACT:
The current invention relates to compounds of the formula: (Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.

REFERENCES:
patent: 7087626 (2006-08-01), Beight et al.
patent: 2006/0040983 (2006-02-01), Beight et al.
patent: 2006/0079680 (2006-04-01), Sawyer
patent: WO 02 062787 (2002-08-01), None
patent: WO 02 062794 (2002-08-01), None
patent: WO 02 066462 (2002-08-01), None
patent: 2002094833 (2002-11-01), None
patent: WO 02 094833 (2002-11-01), None
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, pp. 1-6.
Dermer (Bio/Technology, 1994, 12:320).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds as pharmaceutical agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3905379

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.